Biologics
-
Biologics
Surgeon Creativity Shaping Orthobiologics Innovation
Good relationships with surgeon customers can lead to collaborative development efforts.Online Exclusives Michael Barbella, Managing Editor 05.29.20
-
Biologics | Spine/Neurology
Cerapedics Releases i-FACTOR Peptide Enhanced Bone Graft Lumbar Fusion Trial Results
Elderly patients undergoing non-instrumented fusion achieve statistically significantly higher fusion rate.PR Newswire 05.19.20
-
Biologics | Spine/Neurology
VIVEX Biologics Publishes Initial Clinical Results of VIA Disc
The firm has designed a disc matrix allograft that may offer patients the first non-surgical approach for treating DDD.Globe Newswire 04.30.20
-
Biologics
BONESUPPORT Appoints General Manager and Executive VP
Company's new manager has more than two decades of experience in the orthopedic industry.PR Newswire 04.30.20
-
Biologics
Biocomposites' STIMULAN Earns CE Mark
First calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue.PR Newswire 04.23.20
-
Biologics
Konica Minolta Healthcare Expands Ultrasound Guided Solutions Through RegenLab Partnership
The bio-injectable line includes preparation devices for Platelet Rich Plasma and other blood cell therapies, delivered using ultrasound guidance.Konica Minolta Healthcare Americas Inc. 04.16.20
-
Biologics
Evonik Develops Fermentation-Based Collagen Platform
A substitute for animal-derived collagen in multiple markets.Evonik 03.25.20
-
Biologics | Large Joint
Bone Therapeutics Gains Approval to Trial OA Knee Pain Therapies
Regulatory authorities approve JTA Phase III study in osteoarthritic knee pain, ALLOB Phase IIb study in difficult fractures.Bone Therapeutics 03.25.20
-
Biologics
Made-to-Order Muscles Could Be Served in a Hospital Near You
Dr. Ali Tamayol recently developed a handheld bioprinter pen that could significantly change the way musculoskeletal procedures are performed.Sam Brusco, Associate Editor 03.13.20
-
Biologics
Bone Solutions Reaches 1,000-Implant Milestone for OsteoCrete
Product has a high compressive strength that is three times stronger than the average cancellous bone.PR Newswire 02.26.20
-
Biologics
Study: ARTEBONE Paste Similar to Patient's Own Bone Graft
In addition, the paste showed no safety concerns or product-related complications.Globe Newswire 02.21.20
-
Biologics
Nature’s Way: Promoting the Body's Curative Abilities Through Biologics
A better understanding of cell function, tissue properties, and healing mechanisms are driving growth in the global orthobiologics market.Michael Barbella, Managing Editor 02.18.20
-
Biologics
Bioventus Updates U.S. Label for Ultrasound Bone Healing System
EXOGEN has an 86 percent heal rate for fractures not healing on their own.Bioventus 02.10.20
-
Biologics
Global Bone Graft and Substitutes Market to Reach $4.67B by 2027
Adoption of inorganic growth strategies, increase in road accidents and injuries is expected to boost growth.Business Wire 02.07.20
-
Biologics
Vast Fluctuations Shown in Cost of Orthobiologics
Cost ranged from a few hundred dollars to as much as $12,000.University of Alabama at Birmingham 01.29.20
-
Biologics
Preclinical Study Shows Biologic Effectively Promotes Bone Formation
Results will help Bone Biologics advance its rhNELL-1 growth factor into clinical trials.Business Wire 01.28.20
-
Biologics
Royal Biologics Launches Umbilical Cord Graft
Obtained from mothers during a cesarean delivery, Cryo-Cord is designed to be used as a soft tissue barrier or wound dressing.Globe Newswire 01.24.20
-
Biologics
Arthritis Therapeutics Market to Gain Momentum
Sector is being fueled by the high adoption of biologics, research shows.Persistence Market Research 01.09.20
-
Biologics
Executive VP of Finance Joins MiMedx Management
New hire helped establish Brighthouse Financial after MetLife spinoff three years ago.PR Newswire 01.03.20
-
Biologics
FDA Clears DiFusion Inc.'s Xiphos ZFUZE
First-of-its-kind biomaterial poised to disrupt the PEEK and titanium implant market.Business Wire 12.17.19
